7 results
DEFA14A
TPST
Tempest Therapeutics Inc
19 Nov 18
Additional proxy soliciting materials
5:16pm
Independent Director, is one of the managers of Longwood Fund III GP LLC, the general partner of Longwood Fund III, L.P., which owned 1.56 … of the OvaScience Directors and Executive Officers in the Merger,” as the first full paragraph after the bulleted list.
Mr. Aldrich, OvaScience’s Lead
8-K
TPST
Tempest Therapeutics Inc
19 Nov 18
Other Events
4:58pm
and Executive Officers in the Merger,” as the first full paragraph after the bulleted list.
Mr. Aldrich, OvaScience’s Lead Independent Director
425
TPST
Tempest Therapeutics Inc
19 Nov 18
Business combination disclosure
4:56pm
and Executive Officers in the Merger,” as the first full paragraph after the bulleted list.
Mr. Aldrich, OvaScience’s Lead Independent Director
DEFM14A
TPST
Tempest Therapeutics Inc
6 Nov 18
Proxy related to merger
12:00am
Independent Director, is one of the managers of Longwood Fund III GP LLC, which is the general partner of Longwood Fund III, LP; and
the fact … $241,066.67 of unsecured convertible Promissory notes issued to it by Millendo cancelled as part of that financing and that Richard Aldrich, OvaScience's Lead
424B3
rj4iban
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
a7bkkmh47yxspj8
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
- Prev
- 1
- Next